{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:49:45Z","timestamp":1761058185968},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.femsim.2004.10.012","type":"journal-article","created":{"date-parts":[[2004,12,14]],"date-time":"2004-12-14T15:22:01Z","timestamp":1103037721000},"page":"425-430","source":"Crossref","is-referenced-by-count":8,"title":["Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine"],"prefix":"10.1093","volume":"43","author":[{"given":"Kate","family":"Griffin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Bedford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Townson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Phillpotts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Funnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margret","family":"Morton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Titball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1016\/j.femsim.2004.10.012-BIB1","unstructured":"[1] Anon. (2000). Human plague in 1998 and 1999. World Health Organ. Wkly. Epidemiol. Rec. 75, 337\u00e2\u0080\u0093344"},{"key":"10.1016\/j.femsim.2004.10.012-BIB2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1574-6968.2000.tb09238.x","article-title":"Identification of Yersinia pestis as the causative organism of plague in India as determined by 16S rDNA sequencing and RAPD-based genomic fingerprinting","volume":"189","author":"Shivaji","year":"2000","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.femsim.2004.10.012-BIB3","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon \u00e2\u0080\u0093 medical and public health management","volume":"283","author":"Inglesby","year":"2000","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.femsim.2004.10.012-BIB4","unstructured":"[4] Titball, R.W., Williamson, E.D., Dennis, D.T. (2004) Plague. Plotkin, S.A., Orenstein, W.A., Eds.Vaccines4th edn. W.B Saunders Company, Philadelphia999\u00e2\u0080\u00931010."},{"key":"10.1016\/j.femsim.2004.10.012-BIB5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"Williamson","year":"1995","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.femsim.2004.10.012-BIB6","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0264-410X(98)00426-5","article-title":"Development and clinical application of new polyvalent combined paediatric vaccines","volume":"17","author":"Andre","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.femsim.2004.10.012-BIB7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1067\/mpd.2000.107796","article-title":"Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio virus and Haemophilus influenzae type B vaccines given as either separate or mixed injections","volume":"137","author":"Schmitt","year":"2000","journal-title":"J. Pediatr."},{"key":"10.1016\/j.femsim.2004.10.012-BIB8","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1128\/IAI.51.3.784-787.1986","article-title":"Simultaneous administration of diphtheria\u00e2\u0080\u0093tetanus\u00e2\u0080\u0093pertussis\u00e2\u0080\u0093polio and hepatitis-B vaccines in a simplified immunization program \u00e2\u0080\u0093 immune-response to diphtheria toxoid, tetanus toxoid, pertussis, and hepatitis-B surface-antigen","volume":"51","author":"Coursaget","year":"1986","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2004.10.012-BIB9","first-page":"113","article-title":"Concomitant administration of varicella vaccine with combined measles, mumps, and rubella vaccine in healthy children aged 12 to 24 months of age","volume":"20","author":"Stuck","year":"2002","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.femsim.2004.10.012-BIB10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00006454-199708000-00011","article-title":"Immunogenicity and reactogenicity of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccines given concurrently with Haemophilus type B conjugate vaccine or as pentavalent vaccine","volume":"16","author":"Begue","year":"1997","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.femsim.2004.10.012-BIB11","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/S0264-410X(98)00422-8","article-title":"New acellular pertussis-containing paediatric combined vaccines","volume":"17","author":"Pines","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.femsim.2004.10.012-BIB12","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0140-6736(96)04356-5","article-title":"Randomised trial of the effects of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine","volume":"348","author":"Eskola","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.femsim.2004.10.012-BIB13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0264-410X(98)00162-5","article-title":"Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines","volume":"17","author":"Fattom","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.femsim.2004.10.012-BIB14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1749-6632.1995.tb44436.x","article-title":"Potential alterations in immunogenicity by combining or simultaneously administering vaccine components","volume":"754","author":"Insel","year":"1995","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.femsim.2004.10.012-BIB15","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/IAI.66.5.2093-2098.1998","article-title":"Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants","volume":"66","author":"Dagan","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2004.10.012-BIB16","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(03)13171-6","article-title":"Risk of vaccine failure after haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis","volume":"361","author":"McVernon","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.femsim.2004.10.012-BIB17","first-page":"160","article-title":"Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever plus yellow fever vaccine","volume":"14","author":"Dumas","year":"1997","journal-title":"Adv. Ther."},{"key":"10.1016\/j.femsim.2004.10.012-BIB18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1708-8305.1998.tb00483.x","article-title":"Concomitant vaccination against hepatitis A and typhoid fever","volume":"5","author":"Hoecke","year":"1998","journal-title":"J. Travel Med."},{"key":"10.1016\/j.femsim.2004.10.012-BIB19","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/0264-410X(96)00059-X","article-title":"Interference assessment of yellow fever vaccine with the immune response to a single-dose inactivated hepatitis A vaccine (1440 ELU). A controlled study in adults","volume":"14","author":"Gil","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.femsim.2004.10.012-BIB20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2310\/7060.2000.00025","article-title":"Does the concurrent administration of an inactivated hepatitis A vaccine influence the immune response to other travelers vaccines","volume":"7","author":"Bock","year":"2000","journal-title":"J. Travel Med."},{"key":"10.1016\/j.femsim.2004.10.012-BIB21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02599650","article-title":"Adverse reactions associated with simultaneous administration of multiple vaccines to travelers","volume":"9","author":"Falvo","year":"1994","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.femsim.2004.10.012-BIB22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2310\/7060.2003.31690","article-title":"Tolerability of multiple vaccinations in travel medicine","volume":"10","author":"Borner","year":"2003","journal-title":"J. Travel Med."},{"key":"10.1016\/j.femsim.2004.10.012-BIB23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1084\/jem.172.1.399","article-title":"Regulation of parasite-induced eosinophilia selectively increased IL-5 production in helminth-infected patients","volume":"172","author":"Limaye","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.femsim.2004.10.012-BIB24","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.4049\/jimmunol.148.7.2142","article-title":"Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human TH1 and TH2 clones","volume":"148","author":"Maggi","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.femsim.2004.10.012-BIB25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1126\/science.1925582","article-title":"Defining protective responses to pathogens: cytokine profiles in leprosy lesions","volume":"254","author":"Yamamura","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.femsim.2004.10.012-BIB26","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.180.4.1273","article-title":"Influenza virus-specific CD4+ helper type 2 T-lymphocytes do not promote recovery from experimental virus infection","volume":"180","author":"Graham","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.femsim.2004.10.012-BIB27","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.4049\/jimmunol.138.11.3688","article-title":"Two types of murine helper T cell clones. II. Delayed-type hypersensitivity is mediated by Th1 clones","volume":"138","author":"Cher","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.femsim.2004.10.012-BIB28","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.4049\/jimmunol.146.10.3444","article-title":"Interleukin-10 acts on the antigen-presenting cell to inhibit cytokine production by TH1 cells","volume":"146","author":"Fiorentino","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.femsim.2004.10.012-BIB29","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.4049\/jimmunol.140.12.4245","article-title":"Anti-proliferative effect of IFN-gamma in immune regulation. 1. IFN-gamma inhibits the proliferation of TH2 but not TH1 murine helper lymphocyte-T clones","volume":"140","author":"Gajewski","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.femsim.2004.10.012-BIB30","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1084\/jem.170.5.1751","article-title":"Recombinant IL-4 supresses the production of IFN-gamma by human mononuclear cells","volume":"170","author":"Peleman","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.femsim.2004.10.012-BIB31","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.4049\/jimmunol.136.12.4538","article-title":"B-cell stimulation factor-1 enhances the IgE response of lipopolysaccharide-activated B-cells","volume":"136","author":"Coffman","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.femsim.2004.10.012-BIB32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1615\/CritRevImmunol.v18.i4.10","article-title":"Crossregulation between Th1 and Th2 cells","volume":"18","author":"Morel","year":"1998","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.femsim.2004.10.012-BIB33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0264-410X(00)00123-7","article-title":"An immunological profile of Balb\/c mice protected from airborne challenge following vaccination with a live attenuated Venezuelan equine encephalitis virus vaccine","volume":"19","author":"Bennett","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.femsim.2004.10.012-BIB34","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/IAI.70.4.2022-2028.2002","article-title":"Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2004.10.012-BIB35","first-page":"144","article-title":"Studies on a protective antigen produced in vitro from Bacillus anthracis: medium and methods of production","volume":"35","author":"Belton","year":"1954","journal-title":"Brit. J. Exp. Pathol."},{"key":"10.1016\/j.femsim.2004.10.012-BIB36","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","article-title":"A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunised animals against pneumonic plague","volume":"15","author":"Williamson","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.femsim.2004.10.012-BIB37","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0264-410X(98)00315-6","article-title":"TC-83 vaccine protects against airborne or subcutaneous challenge with heterologous mouse-virulent strains of Venezuelan equine encephalitis virus","volume":"17","author":"Phillpotts","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.femsim.2004.10.012-BIB38","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0264-410X(95)00090-N","article-title":"A comparison of plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model","volume":"13","author":"Russell","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.femsim.2004.10.012-BIB39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1574-695X.1999.tb01229.x","article-title":"The SCID\/Beige mouse as a model to investigate protection against Yersinia pestis","volume":"23","author":"Green","year":"1999","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.femsim.2004.10.012-BIB40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.1999.00859.x","article-title":"An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.femsim.2004.10.012-BIB41","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/383787a0","article-title":"A functional diversity of helper T lymphocytes","volume":"383","author":"Abbas","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.femsim.2004.10.012-BIB42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1988.tb00739.x","article-title":"The role of helper T cell products in mouse B cell differentiation and isotype regulation","volume":"102","author":"Coffman","year":"1988","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.femsim.2004.10.012-BIB43","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/334255a0","article-title":"A. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells","volume":"334","author":"Stevens","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.femsim.2004.10.012-BIB44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2672.1999.00901.x","article-title":"Presentation of protective antigen to the mouse immune system: immune sequelae","volume":"87","author":"Williamson","year":"1999","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.femsim.2004.10.012-BIB45","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1016\/S0264-410X(02)00396-1","article-title":"Protection against plague following immunisation with microencapsulated V antigen is reduced by coencapsulation with IFN-\u00ce\u00b3 or IL-4, but not IL-6","volume":"20","author":"Griffin","year":"2002","journal-title":"Vaccine"}],"container-title":["FEMS Immunology & Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/43\/3\/425\/19168116\/43-3-425.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T21:58:04Z","timestamp":1682891884000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article-lookup\/doi\/10.1016\/j.femsim.2004.10.012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"URL":"https:\/\/doi.org\/10.1016\/j.femsim.2004.10.012","relation":{},"ISSN":["0928-8244","1574-695X"],"issn-type":[{"value":"0928-8244","type":"print"},{"value":"1574-695X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}